Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Rapid Development of a Tool for Prioritizing Patients with Coronavirus Disease 2019 for Intensive Care

View through CrossRef
Objectives: To explain and demonstrate a new approach for rapidly developing a decision-support tool for prioritizing patients with coronovirus 2019 disease for admission to ICUs. Design: An expert group used multi-criteria decision analysis methods to specify criteria and weights, representing their relative importance, for prioritizing patients with coronovirus 2019 disease with respect to likely clinical benefit. Specialized multi-criteria decision analysis software, implementing the “Potentially All Pairwise RanKings of all possible Alternatives” method to determine the weights, was used. Social equity considerations for prioritizing patients were also identified as important. Setting: The prioritization tool was developed in New Zealand. Subjects: An expert group comprising specialists from intensive care medicine and nursing, Māori (New Zealand’s indigenous population) health, infectious diseases, and neonatology was formed. The group’s work was supported by health economists and decision analysts and overseen by an ethicist and a senior representative from the New Zealand Ministry of Health. Interventions: Multi-criteria decision analysis to create a prioritization tool. Measurements and Main Results: The prioritization tool comprised eight criteria with respect to likely clinical benefit. In decreasing order of importance (weights in parentheses): Sequential Organ Failure Assessment score (15.7%), preexisting cardiovascular conditions (15.7%), functional capacity (15.7%), age (12.4%), preexisting respiratory conditions (11.1%), immunocompromised (11.1%), body mass index (9.2%), and other relevant medical conditions (9.2%). Two social equity considerations were also included in the overarching decision framework to be used alongside the clinical criteria: prioritizing Māori and Pacific people (and, potentially, other at-risk groups), and healthcare and other frontline workers. Conclusions: The criteria and weights in the prioritization tool can be easily revised as new evidence emerges. The approach for developing the tool could be used in other countries whose ICUs are at risk of being overwhelmed by the coronavirus disease 2019 pandemic to rapidly develop their own prioritization tools. In the event that future crises threaten to overload ICUs, other prioritization tools could also be rapidly developed.
Title: Rapid Development of a Tool for Prioritizing Patients with Coronavirus Disease 2019 for Intensive Care
Description:
Objectives: To explain and demonstrate a new approach for rapidly developing a decision-support tool for prioritizing patients with coronovirus 2019 disease for admission to ICUs.
Design: An expert group used multi-criteria decision analysis methods to specify criteria and weights, representing their relative importance, for prioritizing patients with coronovirus 2019 disease with respect to likely clinical benefit.
Specialized multi-criteria decision analysis software, implementing the “Potentially All Pairwise RanKings of all possible Alternatives” method to determine the weights, was used.
Social equity considerations for prioritizing patients were also identified as important.
Setting: The prioritization tool was developed in New Zealand.
Subjects: An expert group comprising specialists from intensive care medicine and nursing, Māori (New Zealand’s indigenous population) health, infectious diseases, and neonatology was formed.
The group’s work was supported by health economists and decision analysts and overseen by an ethicist and a senior representative from the New Zealand Ministry of Health.
Interventions: Multi-criteria decision analysis to create a prioritization tool.
Measurements and Main Results: The prioritization tool comprised eight criteria with respect to likely clinical benefit.
In decreasing order of importance (weights in parentheses): Sequential Organ Failure Assessment score (15.
7%), preexisting cardiovascular conditions (15.
7%), functional capacity (15.
7%), age (12.
4%), preexisting respiratory conditions (11.
1%), immunocompromised (11.
1%), body mass index (9.
2%), and other relevant medical conditions (9.
2%).
Two social equity considerations were also included in the overarching decision framework to be used alongside the clinical criteria: prioritizing Māori and Pacific people (and, potentially, other at-risk groups), and healthcare and other frontline workers.
Conclusions: The criteria and weights in the prioritization tool can be easily revised as new evidence emerges.
The approach for developing the tool could be used in other countries whose ICUs are at risk of being overwhelmed by the coronavirus disease 2019 pandemic to rapidly develop their own prioritization tools.
In the event that future crises threaten to overload ICUs, other prioritization tools could also be rapidly developed.

Related Results

Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash Abstract This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Smart manufacturing has been developed since the introduction of Industry 4.0. It consists of resource sharing and networking, predictive engineering, and material and data analyti...
DAMPAK TEKNOLOGI TERHADAP PROSES BELAJAR MENGAJAR
DAMPAK TEKNOLOGI TERHADAP PROSES BELAJAR MENGAJAR
DAFTAR PUSTAKAAditama, M. H. R., & Selfiardy, S. (2022). Kehidupan Mahasiswa Kuliah Sambil Bekerja di Masa Pandemi Covid-19. Kidspedia: Jurnal Pendidikan Anak Usia Dini, 3(...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract Introduction Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
COVID-19 Testing in Young Individuals and Pandemics Monitoring: Low Susceptibility to the Infection and Lack of Positive Results
Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV- 2), a novel betacoronavirus, is the etiological agent of coronavirus disease 2019 (COVID-19), a global health threat. The ...

Back to Top